Literature DB >> 10767821

ACP. Best Practice No 155. Guidelines for handling oesophageal biopsies and resection specimens and their reporting.

N B Ibrahim1.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10767821      PMCID： PMC1763284          DOI： 10.1136/jcp.53.2.89

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  29 in total

Review 1.  Barrett's esophagus. A review of the pathologist's role in diagnosis and management.

Authors:  R E Petras; M V Sivak; T W Rice
Journal:  Pathol Annu       Date:  1991

2.  Lugol staining pattern and histology of esophageal lesions.

Authors:  M Mori; Y Adachi; T Matsushima; H Matsuda; H Kuwano; K Sugimachi
Journal:  Am J Gastroenterol       Date:  1993-05       Impact factor: 10.864

3.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus.

Authors:  B J Reid; R C Haggitt; C E Rubin; G Roth; C M Surawicz; G Van Belle; K Lewin; W M Weinstein; D A Antonioli; H Goldman
Journal:  Hum Pathol       Date:  1988-02       Impact factor: 3.466

4.  The histologic spectrum of Barrett's esophagus.

Authors:  A Paull; J S Trier; M D Dalton; R C Camp; P Loeb; R K Goyal
Journal:  N Engl J Med       Date:  1976-08-26       Impact factor: 91.245

5.  Shrinkage of the esophagus after resection for carcinoma.

Authors:  K F Siu; H C Cheung; J Wong
Journal:  Ann Surg       Date:  1986-02       Impact factor: 12.969

6.  An extensive morphological and comparative study of clinically early and obvious squamous cell carcinoma of the esophagus.

Authors:  P A Anani; D Gardiol; M Savary; P Monnier
Journal:  Pathol Res Pract       Date:  1991-03       Impact factor: 3.250

Review 7.  Sarcomas--a clinicopathological guide with particular reference to cutaneous manifestation. I. Dermatofibrosarcoma protuberans, malignant fibrous histiocytoma and the epithelioid sarcoma of Enzinger.

Authors:  C D Fletcher; P H McKee
Journal:  Clin Exp Dermatol       Date:  1984-09       Impact factor: 3.470

8.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

Authors:  R H Riddell; H Goldman; D F Ransohoff; H D Appelman; C M Fenoglio; R C Haggitt; C Ahren; P Correa; S R Hamilton; B C Morson
Journal:  Hum Pathol       Date:  1983-11       Impact factor: 3.466

9.  Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma.

Authors:  S Y Iftikhar; P D James; R J Steele; J D Hardcastle; M Atkinson
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

10.  Prognosis of operable squamous cell carcinoma of the esophagus. Relationship with clinicopathologic features and DNA ploidy.

Authors:  P Patil; A Redkar; S G Patel; S Krishnamurthy; R C Mistry; R K Deshpande; I Mittra; P B Desai
Journal:  Cancer       Date:  1993-07-01       Impact factor: 6.860
View more
  11 in total

1.  Electronic publishing and internet learning.

Authors:  P J van Diest; H Holzel; M Reid; M Crook; G Spickett
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  Visceral obesity stimulates anaphase bridge formation and spindle assembly checkpoint dysregulation in radioresistant oesophageal adenocarcinoma.

Authors:  A M Mongan; N Lynam-Lennon; R Casey; S Maher; G Pidgeon; J V Reynolds; J O'Sullivan
Journal:  Clin Transl Oncol       Date:  2015-10-16       Impact factor: 3.405

3.  Histopathological assessment of lymph nodes in upper gastrointestinal cancer: does triple levelling detect significantly more metastases?

Authors:  Stephen McGrath; Sarah Cross; Susan Anne Pritchard
Journal:  J Clin Pathol       Date:  2007-02-13       Impact factor: 3.411

4.  Dysplasia in Barrett's Esophagus.

Authors:  Marcos Pedrosa
Journal:  Curr Treat Options Gastroenterol       Date:  2001-02

5.  Clinical puzzle: Barrett's oesophagus.

Authors:  Massimiliano di Pietro; Christopher J Peters; Rebecca C Fitzgerald
Journal:  Dis Model Mech       Date:  2008 Jul-Aug       Impact factor: 5.758

6.  Upper gastrointestinal cancer pathology reporting: a regional audit to compare standards with minimum datasets.

Authors:  P M King; J M Blazeby; J Gupta; D Alderson; M Moorghen
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

7.  Outcomes for Esophageal Squamous Cell Carcinoma Treated with Curative Intent in a Western Cohort: Should Multimodal Therapy Be the Gold Standard?

Authors:  Fiachra Sheil; Claire L Donohoe; Sinéad King; Dermot O'Toole; Moya Cunningham; Sinéad Cuffe; Narayanasamy Ravi; John V Reynolds
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

8.  Impaired transforming growth factor beta signalling in Barrett's carcinogenesis due to frequent SMAD4 inactivation.

Authors:  B A Onwuegbusi; A Aitchison; S-F Chin; T Kranjac; I Mills; Y Huang; P Lao-Sirieix; C Caldas; R C Fitzgerald
Journal:  Gut       Date:  2005-12-20       Impact factor: 23.059

9.  Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology - an update for the surgical oncologist.

Authors:  Ewen A Griffiths; Susan A Pritchard; Nicholas P Mapstone; Ian M Welch
Journal:  World J Surg Oncol       Date:  2006-11-21       Impact factor: 2.754

10.  Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? A study based on West Midlands cancer registration data.

Authors:  B S Kötz; S Croft; D R Ferry
Journal:  Br J Cancer       Date:  2006-09-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.